n-succinimidyl 3-(2-pyridyldithio)propionate and Acute Lymphoid Leukemia

n-succinimidyl 3-(2-pyridyldithio)propionate has been researched along with Acute Lymphoid Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Sun, LR; Wang, LL; Wang, LZ; Zhao, YX	1

Other Studies

1 other study(ies) available for n-succinimidyl 3-(2-pyridyldithio)propionate and Acute Lymphoid Leukemia

Article	Year
Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children. International immunopharmacology, 2011, Volume: 11, Issue:9 Topics: Acetylmuramyl-Alanyl-Isoglutamine; Antibodies, Monoclonal; Antigens, CD; Child; Dendritic Cells; Endocytosis; HL-60 Cells; HLA-DR Antigens; Humans; Immunoconjugates; Immunologic Factors; Immunophenotyping; Immunotherapy; Interleukin-12; Neoplasm, Residual; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Succinimides; T-Lymphocytes; Tumor Cells, Cultured; Up-Regulation	2011

Article

Year

Preparation and identification of a novel immunomodulator composed of muramyl dipeptide and anti-CD10 monoclonal antibody for treatment of minimal residual disease in acute leukemia children.

International immunopharmacology, 2011, Volume: 11, Issue:9

Topics: Acetylmuramyl-Alanyl-Isoglutamine; Antibodies, Monoclonal; Antigens, CD; Child; Dendritic Cells; Endocytosis; HL-60 Cells; HLA-DR Antigens; Humans; Immunoconjugates; Immunologic Factors; Immunophenotyping; Immunotherapy; Interleukin-12; Neoplasm, Residual; Neprilysin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Succinimides; T-Lymphocytes; Tumor Cells, Cultured; Up-Regulation

2011